TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.

Andrew M Evens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.